<code id='1981B01D95'></code><style id='1981B01D95'></style>
    • <acronym id='1981B01D95'></acronym>
      <center id='1981B01D95'><center id='1981B01D95'><tfoot id='1981B01D95'></tfoot></center><abbr id='1981B01D95'><dir id='1981B01D95'><tfoot id='1981B01D95'></tfoot><noframes id='1981B01D95'>

    • <optgroup id='1981B01D95'><strike id='1981B01D95'><sup id='1981B01D95'></sup></strike><code id='1981B01D95'></code></optgroup>
        1. <b id='1981B01D95'><label id='1981B01D95'><select id='1981B01D95'><dt id='1981B01D95'><span id='1981B01D95'></span></dt></select></label></b><u id='1981B01D95'></u>
          <i id='1981B01D95'><strike id='1981B01D95'><tt id='1981B01D95'><pre id='1981B01D95'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:1462
          Teladoc website -- health tech coverage from STAT
          Adobe

          Virtual care company Teladoc has a new chief executive officer following the abrupt departure of its longtime leader in April.

          Chuck Divita, who took on the role Monday, previously led the commercial markets business at GuideWell, the parent company of health plan Florida Blue. He was also previously chief financial officer at FPIC Insurance Group, a publicly traded insurance company focused on medical liability.

          advertisement

          Board chair David Snow said in a release that Divita’s health care experience and tenure at a public company made him an attractive candidate. Divita has also joined Teladoc’s board of directors.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          The mammogram wars are not over
          The mammogram wars are not over

          AdobeNewbreastcancerscreeningguidelinesfromtheUnitedStatesPreventiveServicesTaskForcegivetheimpressi

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

          4:09FormerPresidentDonaldTrumpspeakstosupportersatTrumpNationalGolfClubinBedminsterfollowinghisappea